CareLex works with standards bodies, policy groups, research institutions and organizations such as the National Cancer Institute, HL7, Mayo Clinic, Stanford University, CareLex and many others to advance technologies that drive significant positive advancements in health sciences for humanity. In 2014 CareLex sponsored and led development of the OASIS ETMF Standard for clinical trial content and data classification.
In 2016 the ETMF Standard Model was published by OASIS Open, followed by publication of the ETMF Standard ontology by NCI EVS and the National Center for Bio Ontology (NCBO). Since its publication, the OASIS ETMF Standard has been used by thousands of health science professionals and organizations globally as a tool to automate and optimize manual processes in clinical trial development.
With the explosive growth of AI for drug discovery and development, CareLex’s mission of sponsoring technology standards to optimize, accelerate and enhance quality in healthcare and life sciences will be increasingly important and meaningful.
Have an idea for a new technology initiative that could help health sciences organizations? Contact us today so we can explore collaboration opportunities.
Published and curated open source clinical schemas and AI knowledgegraphs for life sciences and healthcare.
Published and curated open source clinical datasets for use in life sciences and healthcare.
Published open source health science AI applications for use in clinical research and healthcare.
We're a non-profit organization.
Designed for Patient Anonymity
Used in multiple clinical organizations and clinical studies globally.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
CareLex is a suite of open-source clinical intelligence tools and resources designed to enhance decision making accuracy for health science teams, processes and applications. Our mission is to reduce clinical trial timelines through advanced AI tools and automation, yielding higher quality and better outcomes in the discovery of life-saving treatments.